Listed

Black Diamond Therapeutics, Inc.

BDTXNasdaqCIK 1701541HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q2 FY2026
Operating income−$12.1m, Q2 FY2026
Net income−$9.9m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reported0.0Revenue, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-05-12, accession 0001701541-25-000022.Report this figure0.0Revenue, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-08-07, accession 0001701541-25-000030.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-06, accession 0001701541-25-000039.Report this figure0.0Revenue, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-16, accession 0001701541-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure70.0Revenue, Q1 FY2025, three months to 2025-03-31$70.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-07, accession 0001701541-26-000017.Report this figure0.0Revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure0.0Revenue, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-06, accession 0001701541-25-000039.Report this figure0.0Revenue, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-16, accession 0001701541-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-07, accession 0001701541-26-000017.Report this figure0.0Revenue, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure
Research and development$m16.2Research and development, Q3 FY2023, three months to 2023-09-30$16.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-05, accession 0001701541-24-000042.Report this figure15.3Research and development, Q4 FY2023, three months to 2023-12-31$15.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-06, accession 0001701541-25-000016. Derived: 12-month figure less the 9-month figure.Report this figure13.5Research and development, Q1 FY2024, three months to 2024-03-31$13.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0001701541-25-000022.Report this figure12.6Research and development, Q2 FY2024, three months to 2024-06-30$12.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0001701541-25-000030.Report this figure12.9Research and development, Q3 FY2024, three months to 2024-09-30$12.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001701541-25-000039.Report this figure12.3Research and development, Q4 FY2024, three months to 2024-12-31$12.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-16, accession 0001701541-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure10.5Research and development, Q1 FY2025, three months to 2025-03-31$10.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001701541-26-000017.Report this figure9.3Research and development, Q2 FY2025, three months to 2025-06-30$9.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure7.4Research and development, Q3 FY2025, three months to 2025-09-30$7.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001701541-25-000039.Report this figure6.3Research and development, Q4 FY2025, three months to 2025-12-31$6.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-16, accession 0001701541-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure7.0Research and development, Q1 FY2026, three months to 2026-03-31$7.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001701541-26-000017.Report this figure7.4Research and development, Q2 FY2026, three months to 2026-06-30$7.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure
Operating income$m(24.0)Operating income, Q3 FY2023, three months to 2023-09-30−$24.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-05, accession 0001701541-24-000042.Report this figure(20.9)Operating income, Q4 FY2023, three months to 2023-12-31−$20.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-06, accession 0001701541-25-000016. Derived: 12-month figure less the 9-month figure.Report this figure(20.2)Operating income, Q1 FY2024, three months to 2024-03-31−$20.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0001701541-25-000022.Report this figure(22.1)Operating income, Q2 FY2024, three months to 2024-06-30−$22.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0001701541-25-000030.Report this figure(18.1)Operating income, Q3 FY2024, three months to 2024-09-30−$18.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001701541-25-000039.Report this figure(18.3)Operating income, Q4 FY2024, three months to 2024-12-31−$18.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0001701541-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure54.5Operating income, Q1 FY2025, three months to 2025-03-31$54.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001701541-26-000017.Report this figure(13.4)Operating income, Q2 FY2025, three months to 2025-06-30−$13.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure(11.0)Operating income, Q3 FY2025, three months to 2025-09-30−$11.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001701541-25-000039.Report this figure(17.6)Operating income, Q4 FY2025, three months to 2025-12-31−$17.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0001701541-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure(11.3)Operating income, Q1 FY2026, three months to 2026-03-31−$11.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001701541-26-000017.Report this figure(12.1)Operating income, Q2 FY2026, three months to 2026-06-30−$12.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$mnot reportednot reportednot reportednot reportednot reportednot reported0.2Income tax, Q1 FY2025, three months to 2025-03-31$226.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-12, accession 0001701541-25-000022.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0001701541-25-000030. Derived: 6-month figure less the 3-month figure.Report this figurenot reportednot reportednot reportednot reported
Net income$m(23.0)Net income, Q3 FY2023, three months to 2023-09-30−$23.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-05, accession 0001701541-24-000042.Report this figure(19.4)Net income, Q4 FY2023, three months to 2023-12-31−$19.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-06, accession 0001701541-25-000016. Derived: 12-month figure less the 9-month figure.Report this figure(18.2)Net income, Q1 FY2024, three months to 2024-03-31−$18.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001701541-25-000039.Report this figure(19.9)Net income, Q2 FY2024, three months to 2024-06-30−$19.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001701541-25-000039.Report this figure(15.6)Net income, Q3 FY2024, three months to 2024-09-30−$15.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001701541-25-000039.Report this figure(16.0)Net income, Q4 FY2024, three months to 2024-12-31−$16.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0001701541-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure56.5Net income, Q1 FY2025, three months to 2025-03-31$56.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure(10.6)Net income, Q2 FY2025, three months to 2025-06-30−$10.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure(8.5)Net income, Q3 FY2025, three months to 2025-09-30−$8.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001701541-25-000039.Report this figure(15.1)Net income, Q4 FY2025, three months to 2025-12-31−$15.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0001701541-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure(9.0)Net income, Q1 FY2026, three months to 2026-03-31−$9.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure(9.9)Net income, Q2 FY2026, three months to 2026-06-30−$9.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure
Diluted EPS$ per share(0.45)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.45 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-05, accession 0001701541-24-000042.Report this figurenot reported(0.35)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-12, accession 0001701541-25-000022.Report this figure(0.36)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0001701541-25-000030.Report this figure(0.28)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001701541-25-000039.Report this figurenot reported0.98Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.98 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001701541-26-000017.Report this figure(0.19)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure(0.15)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001701541-25-000039.Report this figurenot reported(0.16)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001701541-26-000017.Report this figure(0.17)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure
Basic EPS$ per share(0.45)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.45 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-05, accession 0001701541-24-000042.Report this figurenot reported(0.35)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-12, accession 0001701541-25-000022.Report this figure(0.36)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.36 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0001701541-25-000030.Report this figure(0.28)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001701541-25-000039.Report this figurenot reported1.00Basic EPS, Q1 FY2025, three months to 2025-03-31$1.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001701541-26-000017.Report this figure(0.19)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure(0.15)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001701541-25-000039.Report this figurenot reported(0.16)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001701541-26-000017.Report this figure(0.17)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure

Balance sheet

Cash and equivalents$19.2m, Q2 FY2026
Shareholders' equity$96.1m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m58.0Cash and equivalents, Q3 FY2023, at 2023-09-30$58.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-05, accession 0001701541-24-000042.Report this figure56.2Cash and equivalents, FY2023, at 2023-12-31$56.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-06, accession 0001701541-25-000016.Report this figure25.4Cash and equivalents, Q1 FY2024, at 2024-03-31$25.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0001701541-25-000022.Report this figure32.8Cash and equivalents, Q2 FY2024, at 2024-06-30$32.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0001701541-25-000030.Report this figure23.4Cash and equivalents, Q3 FY2024, at 2024-09-30$23.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001701541-25-000039.Report this figure36.4Cash and equivalents, FY2024, at 2024-12-31$36.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-16, accession 0001701541-26-000009.Report this figure98.4Cash and equivalents, Q1 FY2025, at 2025-03-31$98.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001701541-26-000017.Report this figure30.0Cash and equivalents, Q2 FY2025, at 2025-06-30$30.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure30.9Cash and equivalents, Q3 FY2025, at 2025-09-30$30.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001701541-25-000039.Report this figure21.0Cash and equivalents, FY2025, at 2025-12-31$21.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure30.1Cash and equivalents, Q1 FY2026, at 2026-03-31$30.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001701541-26-000017.Report this figure19.2Cash and equivalents, Q2 FY2026, at 2026-06-30$19.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure
Current assets$m147Current assets, Q3 FY2023, at 2023-09-30$147.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-06, accession 0001701541-23-000047.Report this figure134Current assets, FY2023, at 2023-12-31$134.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-06, accession 0001701541-25-000016.Report this figure119Current assets, Q1 FY2024, at 2024-03-31$118.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0001701541-24-000022.Report this figure127Current assets, Q2 FY2024, at 2024-06-30$126.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-06, accession 0001701541-24-000030.Report this figure116Current assets, Q3 FY2024, at 2024-09-30$115.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-05, accession 0001701541-24-000042.Report this figure101Current assets, FY2024, at 2024-12-31$101.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-16, accession 0001701541-26-000009.Report this figure156Current assets, Q1 FY2025, at 2025-03-31$155.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0001701541-25-000022.Report this figure147Current assets, Q2 FY2025, at 2025-06-30$146.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0001701541-25-000030.Report this figure139Current assets, Q3 FY2025, at 2025-09-30$139.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001701541-25-000039.Report this figure132Current assets, FY2025, at 2025-12-31$132.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure123Current assets, Q1 FY2026, at 2026-03-31$123.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001701541-26-000017.Report this figure115Current assets, Q2 FY2026, at 2026-06-30$115.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure
Total assets$m172Total assets, Q3 FY2023, at 2023-09-30$172.4m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-06, accession 0001701541-23-000047.Report this figure159Total assets, FY2023, at 2023-12-31$158.6m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-06, accession 0001701541-25-000016.Report this figure143Total assets, Q1 FY2024, at 2024-03-31$142.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0001701541-24-000022.Report this figure150Total assets, Q2 FY2024, at 2024-06-30$150.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0001701541-24-000030.Report this figure138Total assets, Q3 FY2024, at 2024-09-30$137.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-05, accession 0001701541-24-000042.Report this figure123Total assets, FY2024, at 2024-12-31$122.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-16, accession 0001701541-26-000009.Report this figure176Total assets, Q1 FY2025, at 2025-03-31$176.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0001701541-25-000022.Report this figure166Total assets, Q2 FY2025, at 2025-06-30$166.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0001701541-25-000030.Report this figure158Total assets, Q3 FY2025, at 2025-09-30$157.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001701541-25-000039.Report this figure143Total assets, FY2025, at 2025-12-31$143.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure133Total assets, Q1 FY2026, at 2026-03-31$132.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001701541-26-000017.Report this figure125Total assets, Q2 FY2026, at 2026-06-30$125.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure
Current liabilities$m15.1Current liabilities, Q3 FY2023, at 2023-09-30$15.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-06, accession 0001701541-23-000047.Report this figure19.6Current liabilities, FY2023, at 2023-12-31$19.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-06, accession 0001701541-25-000016.Report this figure16.9Current liabilities, Q1 FY2024, at 2024-03-31$16.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0001701541-24-000022.Report this figure18.4Current liabilities, Q2 FY2024, at 2024-06-30$18.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-06, accession 0001701541-24-000030.Report this figure20.8Current liabilities, Q3 FY2024, at 2024-09-30$20.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-05, accession 0001701541-24-000042.Report this figure20.6Current liabilities, FY2024, at 2024-12-31$20.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-16, accession 0001701541-26-000009.Report this figure16.8Current liabilities, Q1 FY2025, at 2025-03-31$16.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0001701541-25-000022.Report this figure16.8Current liabilities, Q2 FY2025, at 2025-06-30$16.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0001701541-25-000030.Report this figure15.5Current liabilities, Q3 FY2025, at 2025-09-30$15.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001701541-25-000039.Report this figure15.7Current liabilities, FY2025, at 2025-12-31$15.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure14.5Current liabilities, Q1 FY2026, at 2026-03-31$14.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001701541-26-000017.Report this figure15.8Current liabilities, Q2 FY2026, at 2026-06-30$15.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure
Total liabilities$m38.1Total liabilities, Q3 FY2023, at 2023-09-30$38.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-06, accession 0001701541-23-000047.Report this figure41.8Total liabilities, FY2023, at 2023-12-31$41.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-06, accession 0001701541-25-000016.Report this figure38.2Total liabilities, Q1 FY2024, at 2024-03-31$38.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0001701541-24-000022.Report this figure39.0Total liabilities, Q2 FY2024, at 2024-06-30$39.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-06, accession 0001701541-24-000030.Report this figure40.5Total liabilities, Q3 FY2024, at 2024-09-30$40.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-05, accession 0001701541-24-000042.Report this figure39.4Total liabilities, FY2024, at 2024-12-31$39.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-16, accession 0001701541-26-000009.Report this figure34.7Total liabilities, Q1 FY2025, at 2025-03-31$34.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0001701541-25-000022.Report this figure33.8Total liabilities, Q2 FY2025, at 2025-06-30$33.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0001701541-25-000030.Report this figure31.6Total liabilities, Q3 FY2025, at 2025-09-30$31.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001701541-25-000039.Report this figure30.8Total liabilities, FY2025, at 2025-12-31$30.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure28.6Total liabilities, Q1 FY2026, at 2026-03-31$28.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001701541-26-000017.Report this figure28.9Total liabilities, Q2 FY2026, at 2026-06-30$28.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure
Shareholders' equity$m134Shareholders' equity, Q3 FY2023, at 2023-09-30$134.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-05, accession 0001701541-24-000042.Report this figure117Shareholders' equity, FY2023, at 2023-12-31$116.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-16, accession 0001701541-26-000009.Report this figure104Shareholders' equity, Q1 FY2024, at 2024-03-31$104.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001701541-25-000039.Report this figure111Shareholders' equity, Q2 FY2024, at 2024-06-30$110.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001701541-25-000039.Report this figure97.4Shareholders' equity, Q3 FY2024, at 2024-09-30$97.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001701541-25-000039.Report this figure83.3Shareholders' equity, FY2024, at 2024-12-31$83.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure142Shareholders' equity, Q1 FY2025, at 2025-03-31$141.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure133Shareholders' equity, Q2 FY2025, at 2025-06-30$132.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure126Shareholders' equity, Q3 FY2025, at 2025-09-30$126.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001701541-25-000039.Report this figure112Shareholders' equity, FY2025, at 2025-12-31$112.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure104Shareholders' equity, Q1 FY2026, at 2026-03-31$104.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure96.1Shareholders' equity, Q2 FY2026, at 2026-06-30$96.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure

Cash flow

Operating cash flow−$8.0m, Q2 FY2026
Capital expenditure$0, Q4 FY2024
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(18.4)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$18.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-05, accession 0001701541-24-000042. Derived: 9-month figure less the 6-month figure.Report this figure(14.0)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$14.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-06, accession 0001701541-25-000016. Derived: 12-month figure less the 9-month figure.Report this figure(21.2)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$21.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0001701541-25-000022.Report this figure(14.7)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$14.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0001701541-25-000030. Derived: 6-month figure less the 3-month figure.Report this figure(11.3)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$11.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001701541-25-000039. Derived: 9-month figure less the 6-month figure.Report this figure(15.1)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$15.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0001701541-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure53.4Operating cash flow, Q1 FY2025, three months to 2025-03-31$53.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001701541-26-000017.Report this figure(9.2)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$9.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001701541-26-000025. Derived: 6-month figure less the 3-month figure.Report this figure(7.9)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$7.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001701541-25-000039. Derived: 9-month figure less the 6-month figure.Report this figure(6.8)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$6.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0001701541-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure(10.2)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$10.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001701541-26-000017.Report this figure(8.0)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$8.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001701541-26-000025. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$33.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-05, accession 0001701541-24-000042. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-06, accession 0001701541-25-000016. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reported0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-06, accession 0001701541-25-000016. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)57.37m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares36.3Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3036,346,181 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-06, accession 0001701541-23-000047.Report this figure36.5Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3136,483,878 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0001701541-24-000022.Report this figure36.5Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3036,516,114 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-06, accession 0001701541-24-000030.Report this figure50.9Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3050,943,155 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-05, accession 0001701541-24-000042.Report this figure51.8Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3151,808,849 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0001701541-25-000022.Report this figure55.2Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3055,155,220 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0001701541-25-000030.Report this figure56.5Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3056,507,956 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001701541-25-000039.Report this figure57.7Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3157,673,099 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001701541-26-000017.Report this figure56.8Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3056,803,450 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure56.9Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3056,929,103 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001701541-25-000039.Report this figure57.2Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3157,233,413 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001701541-26-000017.Report this figure57.4Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3057,367,283 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure

Shares outstanding: 57.45mShares outstanding, period not labelled, at 2026-07-3057,453,747 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001701541-26-000025.Report this figure at Jul 30, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.